Argonaute RISC catalytic component Recombinant Antbody Kit (KD-Validated)

Overview
Catalog #	bsm-90315r-50µL
Product Name	Argonaute RISC catalytic component Recombinant Antbody Kit (KD-Validated)
Applications	WB, FCM, IC
Specificity	Knockdown Validated
Reactivity	Human, Mouse, Rat
Specifications
Conjugation	Unconjugated
Host	Rabbit
Source	A synthesized peptide derived from human Argonaute 2
Immunogen Range	370-420/859
Clonality	Recombinant
Isotype	IgG
Concentration	Lot dependent
Purification	Affinity Purified
Storage Buffer	0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol
Storage Condition	-20 °C
Target
Gene ID	27161
Swiss Prot	Q9UKV8
Synonyms	AGO2; Argonaute RISC Catalytic Component 2; LINC00980; EIF2C2; Q10; Cancer Susceptibility Candidate 7 (Non-Protein Coding); Eukaryotic Translation Initiation Factor 2C 2; PAZ Piwi Domain Protein; Protein Argonaute-2; Protein Slicer; HAGO2; CASC7; PPD; Eukaryotic Translation Initiation Factor 2C 2; Long Intergenic Non-Protein Coding RNA 980; Argonaute 2 RISC Catalytic Component; EC 3.1.26.N2; EC 3.1.26.N1; Argonaute 2; Argonaute2; EIF-2C 2; LESKRES; EIF2C 2; HAgo2
Background	Cell Line: HeLa Knockdown technology: shRNA Knockdown
Application Dilution
WB	1:300-5000
FCM	1:20-100
IC	1:1000